Skip to content
BOE-A-2026-4354 ·25 February 2026 ·Resolution Medium impact
Tax

Pharmaceutical companies: 1 January 2026 deadline for new salary scales

The Resolution of 12 February 2026 publishes the final new 2025 salary scales for the Pharmaceutical Federation Collective Agreement (SCCL), effective from 1 January 2026. These amendments affect wages under Articles 3, 28.1, 32, and the new Article 47 Bis, as well as Annexes 3 and 4, in accordance with Articles 90.2 and 3 of RDL 2/2015 and Royal Decree 713/2010.

In 2 key points

  1. Application of new salary scales from 1 January 2026 (art. 3, 28.1, 32, 47 Bis y anexos 3 y 4)
  2. Amendments based on RDL 2/2015 and Royal Decree 713/2010 (art. 90.2 y 3 del RDL 2/2015)

How it affects those involved

Pharmaceutical companies must adjust salaries from 1 January 2026 in accordance with the new salary scales. Employees may see changes to their remuneration. Advisors and HR departments must verify salary changes based on the modified articles. Public administrations managing the agreement must ensure that adjustments are applied correctly.

Lifecycle

2026-02-25PublishedPublished in the BOE
2026-01-01Into forceComes into force (con efectos desde el 1 de enero de 2026)
Official text Based on BOE data (boe.es). Information, not advice.

Does this provision affect you?

The tax team reviews your specific situation.

Talk to the tax team
This analysis is informational only and does not constitute legal advice or create a client-adviser relationship. BM Consulting.
Email
Contact